FDA Clears First Device to Automatically Dose Insulin for Type 2 Diabetes

FDA Clears First Device to Automatically Dose Insulin for Type 2 DiabetesThe FDA has approved Insulet SmartAdjust automatic insulin dosing technology for type 2 diabetes in those aged 18 and older. The interoperable automated glycemic controller software connects to an alternate controller-enabled insulin pump (ACE pump) and integrated continuous glucose monitor (ICGM). Together, they automatically adjust insulin delivery to those with diabetes. Prior to clearance, the […]

The post FDA Clears First Device to Automatically Dose Insulin for Type 2 Diabetes appeared first on Techopedia.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!